Brief: Armata Pharmaceuticals Inc - QTRLY Loss Per Share $0.73
12/11/2019 21:22
Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES THIRD QUARTER RESULTS AND
PROVIDES CORPORATE AND CLINICAL UPDATE
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.73
Source text for Eikon: ID:nPn3gqdnMa
Further company coverage: ARMP.A
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles